[Forbes, Getty Images] If you’re like pretty well everyone else, you’re closely watching Gilead Sciences (GILD), creator of remdesivir, a drug that, last week, showed progress in treating the coronavirus in a US government study. But does that make Gilead a good stock to buy now, particularly if you’re focused on income? […]
Read More
[Buck Bully, Getty Images] There’s no doubt we are in a epic pandemic with serious financial ramifications. Tens of millions of jobs were lost this month, and millions filed for unemployment. More than a million cases of coronavirus have been reported in the US. And it seems we are millions […]
Read More
[Zachs, BigStock] In the wake of the coronavirus pandemic, sweeping travel bans, cancellation of large events as well as shutting down of schools, colleges, universities, restaurants and bars, and shopping malls are being observed globally. In such a scenario, people are increasingly resorting to modes of in-house entertainment like video […]
Read More
[Investors] Shares of MRNA stock rocketed Friday after the biotech said it will receive up to $483 million in federal funding for its coronavirus vaccine. The Biomedical Advanced Research and Development Authority, or BARDA — under the U.S. Department of Health and Human Services — will fund the development of Moderna’s coronavirus vaccine, […]
Read More